New York Life Investment Management’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,188
Closed -$635K 778
2025
Q3
$635K Sell
22,188
-663
-3% -$20K 0.01% 742
2025
Q2
$678K Sell
22,851
-528
-2% -$16.4K 0.01% 716
2025
Q1
$775K Buy
23,379
+135
+0.6% +$4.8K 0.01% 702
2024
Q4
$795K Sell
23,244
-2,307
-9% -$86.8K 0.01% 710
2024
Q3
$925K Sell
25,551
-1,465
-5% -$51.4K 0.01% 711
2024
Q2
$923K Buy
27,016
+4,721
+21% +$161K 0.01% 700
2024
Q1
$767K Sell
22,295
-954
-4% -$31.2K 0.01% 736
2023
Q4
$790K Sell
23,249
-320
-1% -$9.58K 0.01% 718
2023
Q3
$634K Buy
23,569
+12,484
+113% +$366K 0.01% 723
2023
Q2
$364K Buy
+11,085
New +$344K ﹤0.01% 1128

Other funds holding AXTA

New York Life Investment Management's AXTA Position: Q4 2025 in Review

New York Life Investment Management sold out of Axalta (AXTA) in Q4 2025, closing a stake of 22,188 shares — an estimated $635K sold.

New York Life Investment Management first reported a position in AXTA in Q2 2023 and held it in 10 quarters. The position peaked at $925K in Q3 2024. 416 funds tracked by Wall St. Rank hold AXTA as of Q4 2025.

  • New York Life Investment Management reported no remaining Axalta position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 22,188 Axalta shares in Q4 2025, an estimated $635K.
  • New York Life Investment Management first reported a position in Axalta in Q2 2023 and held it in 10 quarters.
  • New York Life Investment Management's Axalta position peaked at $925K in Q3 2024.
  • 416 funds tracked by Wall St. Rank held Axalta as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.